Overview

A 5-year Study to Test BI 655130 in Patients With Generalized Pustular Psoriasis Who Took Part in Previous Studies With BI 655130

Status:
Recruiting
Trial end date:
2028-01-20
Target enrollment:
Participant gender:
Summary
To evaluate the long-term safety and efficacy of BI 655130 in patients with GPP, who have completed previous BI 655130 trials and are qualified for entry in this trial
Phase:
Phase 2
Details
Lead Sponsor:
Boehringer Ingelheim